In this review, we will focus on the metabolic effects of IGF-1, the concept of metabolic syndrome and its clinical manifestations (impaired lipid profile, insulin resistance, increased glucose levels, obesity, and cardiovascular disease), discussing whether IGF-1 replacement therapy could be a beneficial strategy for these patients
Verify current rates using the CMS Physician Fee Schedule search tool
There is no clinically validated human dosing protocol
Adenomas often cannot be differentiated definitively from HCC or hypervascular metastases with ultrasonography, CT, or MRI
Your Journey is Personal
Current research suggests these peptides work synergistically, with BPC-157 primarily driving angiogenesis and cytoprotection while TB-500 focuses on actin-mediated cellular migration and structural remodeling